SPARCL1
Basic information
Region (hg38): 4:87473335-87531061
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPARCL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 31 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 32 | 1 | 0 |
Variants in SPARCL1
This is a list of pathogenic ClinVar variants found in the SPARCL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-87479514-T-C | not specified | Uncertain significance (May 06, 2024) | ||
4-87479528-A-G | not specified | Uncertain significance (Apr 09, 2024) | ||
4-87480385-G-A | not specified | Uncertain significance (Mar 11, 2024) | ||
4-87480493-T-C | not specified | Uncertain significance (Jan 10, 2023) | ||
4-87482465-A-T | not specified | Uncertain significance (Jun 27, 2022) | ||
4-87482516-G-A | not specified | Uncertain significance (Dec 02, 2022) | ||
4-87482558-T-C | not specified | Uncertain significance (May 31, 2023) | ||
4-87490335-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
4-87490342-T-A | not specified | Uncertain significance (May 27, 2022) | ||
4-87490351-G-T | not specified | Uncertain significance (Jun 02, 2023) | ||
4-87490377-T-C | not specified | Uncertain significance (Mar 23, 2022) | ||
4-87493595-C-G | not specified | Uncertain significance (Mar 06, 2023) | ||
4-87493595-C-T | not specified | Uncertain significance (Feb 27, 2024) | ||
4-87493602-C-G | not specified | Uncertain significance (Apr 07, 2023) | ||
4-87493670-A-G | not specified | Uncertain significance (May 17, 2023) | ||
4-87493748-T-G | not specified | Uncertain significance (Mar 06, 2023) | ||
4-87493755-C-T | not specified | Uncertain significance (Nov 21, 2022) | ||
4-87493766-CCAT-C | SPARCL1-related disorder | Uncertain significance (Feb 09, 2023) | ||
4-87493808-G-A | not specified | Likely benign (Apr 15, 2024) | ||
4-87493818-C-T | not specified | Uncertain significance (Apr 28, 2022) | ||
4-87493829-G-A | SPARCL1-related disorder | Uncertain significance (Jan 11, 2023) | ||
4-87493883-C-G | not specified | Uncertain significance (Jul 27, 2022) | ||
4-87493909-C-A | not specified | Uncertain significance (Jul 27, 2022) | ||
4-87493950-C-T | not specified | Likely benign (Aug 30, 2022) | ||
4-87493985-G-T | not specified | Uncertain significance (Nov 09, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SPARCL1 | protein_coding | protein_coding | ENST00000418378 | 10 | 57727 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.64e-10 | 0.843 | 125709 | 0 | 38 | 125747 | 0.000151 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0639 | 337 | 340 | 0.990 | 0.0000162 | 4481 |
Missense in Polyphen | 95 | 99.348 | 0.95624 | 1305 | ||
Synonymous | 0.944 | 110 | 123 | 0.892 | 0.00000641 | 1127 |
Loss of Function | 1.70 | 19 | 28.8 | 0.659 | 0.00000131 | 384 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000203 | 0.000203 |
Ashkenazi Jewish | 0.0000995 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000928 | 0.0000924 |
European (Non-Finnish) | 0.000151 | 0.000149 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000371 | 0.000359 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
(Consensus)
Recessive Scores
- pRec
- 0.0870
Intolerance Scores
- loftool
- 0.456
- rvis_EVS
- 0.51
- rvis_percentile_EVS
- 80.3
Haploinsufficiency Scores
- pHI
- 0.112
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.478
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.331
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sparcl1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- signal transduction;post-translational protein modification;cellular protein metabolic process;synaptic membrane adhesion
- Cellular component
- extracellular region;extracellular space;endoplasmic reticulum lumen;collagen-containing extracellular matrix;glutamatergic synapse
- Molecular function
- calcium ion binding;protein binding;collagen binding;extracellular matrix binding